deubiquitin
enzym
emerg
oncolog
antivir
target
reverdi
et
al
issu
chemistri
biolog
disclos
first
smallmolecul
inhibitor
select
recapitul
knockdown
cancer
cell
henc
demonstr
therapeut
feasibl
inhibitor
coval
modif
cellular
protein
ubiquitin
ub
repres
highli
versatil
posttransl
mechan
underpin
proteasom
degrad
regul
divers
array
cellular
process
komand
et
al
reyesturcu
et
al
defect
ubiquitinbas
control
mechan
implic
pathogenesi
numer
diseas
state
includ
cancer
chronic
diseas
viral
infect
lindner
singhal
et
al
henc
compon
ubiquitin
system
emerg
attract
drug
target
reinforc
approv
proteasom
inhibitor
velcad
oncolog
protein
ubiquitin
dynam
revers
process
control
coordin
action
multipl
ubiquitinconjug
deubiquitin
enzym
dub
human
genom
contain
nearli
dub
divid
five
structur
class
enzym
target
inhibitor
discoveri
colland
cowork
reverdi
et
al
part
ubiquitinspecif
proteas
usp
class
group
cystein
proteas
compris
approxim
member
sever
studi
link
diseas
particularli
cancer
enzym
consid
promis
target
drug
discoveri
nicholson
suresh
kumar
major
hurdl
discoveri
inhibitor
cystein
proteas
papainlik
fold
achiev
inhibitori
select
due
rel
shallow
substratebind
site
line
residu
well
conserv
larg
famili
homolog
enzym
moreov
highthroughput
screen
ht
hit
accept
inhibitori
potenc
often
display
desir
level
select
requir
optim
nonetheless
ht
campaign
led
sever
activ
sitedirect
smallmolecul
usp
inhibitor
cyanoindenopyrazin
deriv
hbx
disclos
revers
uncompetit
low
mm
inhibitor
human
modest
select
sever
dub
cystein
proteas
colland
et
al
reverdi
et
al
anoth
compound
found
inhibit
proteaseomeactiv
form
human
mm
rang
inhibit
isot
human
weaker
lee
et
al
sever
structur
unrel
inhibitor
human
discov
mm
rang
inhibit
least
one
human
usp
similar
potenc
chen
et
al
recent
effort
field
lead
compound
often
limit
assess
select
perhap
success
select
inhibit
usp
achiev
plpro
sar
coronaviru
smallmolecul
noncoval
substratebindingsitedirect
inhibitor
viral
usp
discov
mm
rang
potenc
excel
select
profil
ratia
et
al
high
select
like
afford
rel
diverg
viral
usp
human
usp
structur
function
case
inhibitor
test
limit
set
usp
dub
issu
chemistri
biolog
reverdi
et
al
report
deriv
amidotetrahydroacridin
inhibitor
mm
rang
identifi
vitro
enzymat
ht
importantli
compound
show
good
select
test
human
usp
dub
interest
commend
aspect
use
activitybas
molecular
probe
haubv
label
activ
cellular
usp
give
access
larg
repertoir
usp
therefor
permit
thorough
evalu
inhibitori
select
select
data
obtain
vitro
cell
lysat
use
haubv
indic
inhibitor
hbx
reduc
label
label
activ
usp
endogen
express
physiolog
condit
moreov
inhibitor
specif
hit
target
live
cell
disrupt
haubv
competit
label
without
offtarget
activ
across
sever
differ
endogen
deubiquitin
activ
cancer
cell
sever
effect
inhibitor
monitor
aim
recapitul
silenc
includ
compromis
uvinduc
phosphoryl
decreas
level
checkpoint
mediat
claspin
modul
endogen
level
addit
substrat
observ
destabil
addit
inhibitor
reduc
cell
prolifer
induc
caspas
activ
parp
cleavag
arrest
colon
cancer
cell
result
strongli
suggest
discov
compound
display
appreci
level
potenc
select
toward
irrevers
activesitedirect
inhibit
mechan
propos
base
mass
spectrometri
experi
coval
bond
form
catalyt
interestingli
mass
differ
da
lost
coval
inhibit
consist
displac
substitu
activ
site
thiolat
propos
inhibit
mechan
unusu
exploit
field
cystein
proteas
inhibit
far
aromat
chlorin
activ
tetrahydroacridin
system
may
render
mechan
possibl
molecular
dock
inhibitor
posit
cl
substitu
proxim
activ
site
cy
agreement
propos
mechan
requir
posit
charg
amin
substitu
interact
neg
charg
residu
intriguingli
author
specul
inhibit
may
actual
occur
inact
state
featur
misalign
catalyt
triad
rel
limit
number
usp
structur
solv
date
show
substrateinduc
conform
chang
involv
mostli
loop
movement
catalyt
triad
misalign
confirm
therefor
compound
might
inde
exploit
uniqu
structur
featur
achiev
select
structur
determin
enzymeinhibitor
complex
complement
structurefunct
studi
need
confirm
mechanist
hypothes
would
interest
see
whether
reactiv
cl
substitu
optim
sinc
weak
label
anoth
solventexpos
cy
residu
also
note
inhibitor
discoveri
character
describ
reverdi
et
al
provid
gener
proofofprincipl
select
smallmolecul
inhibitor
identifi
enzym
famili
like
usp
signific
achiev
consid
concentr
activ
site
region
perceiv
intract
achiev
inhibitori
select
due
particip
usp
complex
protein
network
multipl
biolog
function
tremend
possibl
offtarget
effect
overlook
rout
inhibitor
drug
certainli
trivial
one
predict
compound
display
good
safeti
profil
howev
identif
inhibitor
bind
select
modul
steadyst
level
substrat
view
step
right
direct
open
excit
avenu
toward
potenti
therapeut
intervent
